January 20, 2014 | Israeli biopharmaceutical company RedHill Biopharma has announced that it has raised $20 million over two consecutive weeks. The company, which acquires drugs and treatments in late clinical trial stages and then finalizes development, raised some of the money from VCs and some in the form of a share offering.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Red Algae Can Treat Wounds And Infections
January 26, 2023

Freight Planner Lists on Nasdaq And Raises $80M
January 26, 2023

$6M Investment For “Lettuce Milk” Startup
January 25, 2023

Israel Has World’s Best Value Internet
January 25, 2023
Facebook comments